TYRO3_HUMAN - dbPTM
TYRO3_HUMAN - PTM Information in dbPTM
Basic Information of Protein
UniProt ID TYRO3_HUMAN
UniProt AC Q06418
Protein Name Tyrosine-protein kinase receptor TYRO3
Gene Name TYRO3
Organism Homo sapiens (Human).
Sequence Length 890
Subcellular Localization Cell membrane
Single-pass type I membrane protein.
Protein Description Receptor tyrosine kinase that transduces signals from the extracellular matrix into the cytoplasm by binding to several ligands including TULP1 or GAS6. Regulates many physiological processes including cell survival, migration and differentiation. Ligand binding at the cell surface induces dimerization and autophosphorylation of TYRO3 on its intracellular domain that provides docking sites for downstream signaling molecules. Following activation by ligand, interacts with PIK3R1 and thereby enhances PI3-kinase activity. Activates the AKT survival pathway, including nuclear translocation of NF-kappa-B and up-regulation of transcription of NF-kappa-B-regulated genes. TYRO3 signaling plays a role in various processes such as neuron protection from excitotoxic injury, platelet aggregation and cytoskeleton reorganization. Plays also an important role in inhibition of Toll-like receptors (TLRs)-mediated innate immune response by activating STAT1, which selectively induces production of suppressors of cytokine signaling SOCS1 and SOCS3.; (Microbial infection) Acts as a receptor for lassa virus and lymphocytic choriomeningitis virus, possibly through GAS6 binding to phosphatidyl-serine at the surface of virion envelope.; (Microbial infection) Acts as a receptor for Ebolavirus, possibly through GAS6 binding to phosphatidyl-serine at the surface of virion envelope..
Protein Sequence MALRRSMGRPGLPPLPLPPPPRLGLLLAALASLLLPESAAAGLKLMGAPVKLTVSQGQPVKLNCSVEGMEEPDIQWVKDGAVVQNLDQLYIPVSEQHWIGFLSLKSVERSDAGRYWCQVEDGGETEISQPVWLTVEGVPFFTVEPKDLAVPPNAPFQLSCEAVGPPEPVTIVWWRGTTKIGGPAPSPSVLNVTGVTQSTMFSCEAHNLKGLASSRTATVHLQALPAAPFNITVTKLSSSNASVAWMPGADGRALLQSCTVQVTQAPGGWEVLAVVVPVPPFTCLLRDLVPATNYSLRVRCANALGPSPYADWVPFQTKGLAPASAPQNLHAIRTDSGLILEWEEVIPEAPLEGPLGPYKLSWVQDNGTQDELTVEGTRANLTGWDPQKDLIVRVCVSNAVGCGPWSQPLVVSSHDRAGQQGPPHSRTSWVPVVLGVLTALVTAAALALILLRKRRKETRFGQAFDSVMARGEPAVHFRAARSFNRERPERIEATLDSLGISDELKEKLEDVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLIRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVQSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIGGNRLKQPPECMEDVYDLMYQCWSADPKQRPSFTCLRMELENILGQLSVLSASQDPLYINIERAEEPTAGGSLELPGRDQPYSGAGDGSGMGAVGGTPSDCRYILTPGGLAEQPGQAEHQPESPLNETQRLLLLQQGLLPHSSC
Overview of Protein Modification Sites with Functional and Structural Information
Experimental Post-Translational Modification Sites

* ASA = Accessible Surface Area

Locations Modification Substrate Peptides
&
Secondary Structure
ASA (%) Reference Orthologous
Protein Cluster
6Phosphorylation--MALRRSMGRPGLP
--CCCCCCCCCCCCC
21.1030631047
63N-linked_GlycosylationQGQPVKLNCSVEGME
CCCCEEEEEEECCCC
15.42UniProtKB CARBOHYD
191N-linked_GlycosylationAPSPSVLNVTGVTQS
CCCCCEEEEECCCCC
27.44UniProtKB CARBOHYD
230N-linked_GlycosylationALPAAPFNITVTKLS
ECCCCCEEEEEEECC
28.14UniProtKB CARBOHYD
240N-linked_GlycosylationVTKLSSSNASVAWMP
EEECCCCCCEEEECC
37.88UniProtKB CARBOHYD
293N-linked_GlycosylationRDLVPATNYSLRVRC
HHHCCCCCCEEEEEE
26.88UniProtKB CARBOHYD
295PhosphorylationLVPATNYSLRVRCAN
HCCCCCCEEEEEEHH
16.2724719451
307PhosphorylationCANALGPSPYADWVP
EHHHCCCCCCCCCCC
28.83-
366N-linked_GlycosylationKLSWVQDNGTQDELT
EEEEEEECCCCCEEE
38.02UniProtKB CARBOHYD
380N-linked_GlycosylationTVEGTRANLTGWDPQ
EEEECCCCCCCCCCC
34.54UniProtKB CARBOHYD
427PhosphorylationQGPPHSRTSWVPVVL
CCCCCCCCCHHHHHH
29.92-
428PhosphorylationGPPHSRTSWVPVVLG
CCCCCCCCHHHHHHH
25.60-
466PhosphorylationRFGQAFDSVMARGEP
HHHHHHHHHHHCCCC
13.8230266825
482PhosphorylationVHFRAARSFNRERPE
HHHHHCCCCCCCCHH
23.3428102081
507UbiquitinationISDELKEKLEDVLIP
CCHHHHHHHHHCCCC
56.44-
526UbiquitinationTLGRMLGKGEFGSVR
CHHHHCCCCCCCCCE
51.83-
543PhosphorylationQLKQEDGSFVKVAVK
HHHCCCCCHHHHHHH
38.9121815630
582UbiquitinationFDHPHVAKLVGVSLR
CCCHHHHHHHHHHHH
42.4921890473
681PhosphorylationFGLSRKIYSGDYYRQ
CCCCCCCCCCCHHHC
15.0527273156
682PhosphorylationGLSRKIYSGDYYRQG
CCCCCCCCCCHHHCC
28.7628796482
685PhosphorylationRKIYSGDYYRQGCAS
CCCCCCCHHHCCCHH
12.2227273156
686PhosphorylationKIYSGDYYRQGCASK
CCCCCCHHHCCCHHC
10.9522322096
731PhosphorylationEIMTRGQTPYAGIEN
HHHHCCCCCCCCCCC
22.5330622161
733PhosphorylationMTRGQTPYAGIENAE
HHCCCCCCCCCCCHH
22.3530622161
804PhosphorylationSASQDPLYINIERAE
CCCCCCEEEEEEECC
9.41-
814PhosphorylationIERAEEPTAGGSLEL
EEECCCCCCCCCEEC
41.0129255136
818PhosphorylationEEPTAGGSLELPGRD
CCCCCCCCEECCCCC
20.1123401153
828PhosphorylationLPGRDQPYSGAGDGS
CCCCCCCCCCCCCCC
17.6919702290
829PhosphorylationPGRDQPYSGAGDGSG
CCCCCCCCCCCCCCC
28.9329978859
835PhosphorylationYSGAGDGSGMGAVGG
CCCCCCCCCCCCCCC
30.2829978859
849PhosphorylationGTPSDCRYILTPGGL
CCHHCCCEEECCCCH
13.4528152594
852PhosphorylationSDCRYILTPGGLAEQ
HCCCEEECCCCHHCC
15.4430266825
869PhosphorylationQAEHQPESPLNETQR
CCCCCCCCCCCHHHH
41.1730266825
874PhosphorylationPESPLNETQRLLLLQ
CCCCCCHHHHHHHHH
20.2330266825
888PhosphorylationQQGLLPHSSC-----
HCCCCCCCCC-----
31.3129978859
889PhosphorylationQGLLPHSSC------
CCCCCCCCC------
22.3224719451

Upstream regulatory proteins (kinases for phosphorylation sites, E3 ubiquitin ligases of ubiquitination sites, ...)
Modified Location Modified Residue Modification Type of Upstream Proteins Gene Name of Upstream Proteins UniProt AC of Upstream Proteins Sources

Oops, there are no upstream regulatory protein records of TYRO3_HUMAN !!

Functions of PTM Sites
Modified Location Modified Residue Modification Function Reference

Oops, there are no descriptions of PTM sites of TYRO3_HUMAN !!

Disease-associated PTM Sites based on SAP

* Distance = the distance between SAP position and PTM sites.

Modified Location Modification Variant Position
(Distance <= 10)
Residue Change SAP Related Disease Reference

Oops, there are no SNP-PTM records of TYRO3_HUMAN !!

Protein-Protein Interaction
Interacting Protein Gene Name Interaction Type PPI Reference Domain-Domain Interactions
SRC_HUMANSRCphysical
7537495
P85A_HUMANPIK3R1physical
10627473
GAS6_HUMANGAS6physical
8621659
VIGLN_HUMANHDLBPphysical
22939629
KLK4_HUMANKLK4physical
25416956
KRA42_HUMANKRTAP4-2physical
25416956
K1C40_HUMANKRT40physical
25416956
KR107_HUMANKRTAP10-7physical
25416956
KR109_HUMANKRTAP10-9physical
25416956
KR108_HUMANKRTAP10-8physical
25416956
KR103_HUMANKRTAP10-3physical
25416956
CTDS1_HUMANCTDSP1physical
28065597
CTDS2_HUMANCTDSP2physical
28065597

Drug and Disease Associations
Kegg Disease
There are no disease associations of PTM sites.
OMIM Disease
There are no disease associations of PTM sites.
Kegg Drug
There are no disease associations of PTM sites.
DrugBank
There are no disease associations of PTM sites.
Regulatory Network of TYRO3_HUMAN

loading...

Related Literatures of Post-Translational Modification

TOP